Insulin resistance and its relationship with high molecular weight adiponectin in adolescents with polycystic ovary syndrome and a maternal history of polycystic ovary syndrome

Fertility and Sterility

Volumn 102, Issue 3, 2014, Pages 826-830

  Cankaya, Sevil ^a   Demir, Berfu ^b   Aksakal, Sezin Erturk ^b   Dilbaz, Berna ^b   Demirtas, Canan ^c   Goktolga, Umit ^d  

^a Kovancilar State Hospital   (Turkey)

^b Etlik Zübeyde HanIm Maternity and Women's Health Teaching and Research Hospital   (Turkey)

^c GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

^d Kosovo Pay Hospital and IVF Clinic Kosovo Kosovo Pay Hospital IVF Clinic   (Serbia)

Author keywords

High molecular weight adiponectin; insulin resistance; polycystic ovary syndrome

Indexed keywords

ADIPONECTIN; GLUCOSE; INSULIN; LIPID; THYROXINE;

ADOLESCENT; ARTICLE; BODY MASS; CASE CONTROL STUDY; CLINICAL ARTICLE; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; CORRELATION ANALYSIS; FAMILY HISTORY; FEMALE; FREE THYROXINE INDEX; HIGH RISK PATIENT; HOMEOSTASIS MODEL OF ASSESSMENT; HUMAN; HYPERANDROGENISM; INSULIN RESISTANCE; MATERNAL DISEASE; MOLECULAR WEIGHT; ORAL GLUCOSE TOLERANCE TEST; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; PROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE;

HIGH MOLECULAR WEIGHT ADIPONECTIN; INSULIN RESISTANCE; POLYCYSTIC OVARY SYNDROME;

ADIPONECTIN; ADOLESCENT; CASE-CONTROL STUDIES; CHILD OF IMPAIRED PARENTS; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN RESISTANCE; MOLECULAR WEIGHT; POLYCYSTIC OVARY SYNDROME; YOUNG ADULT;

EID: 84906936379     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2014.05.032     Document Type: Article

References (41)

1. S. Franks The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group Polycystic ovary syndrome N Engl J Med 333 1995 853 861
2. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS) Hum Reprod 19 2004 41 47
3. A. Dunaif, K.R. Segal, W. Futterweit, and A. Dobrjansky Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome Diabetes 38 1989 1165 1174
4. T. Yokota, K. Oritani, I. Takahashi, J. Ishikawa, A. Matsuyama, and N. Ouchi et al. Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages Blood 96 2000 1723 1732
5. M. Fasshauer, J. Klein, S. Neumann, M. Eszlinger, and R. Paschke Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes Biochem Biophys Res Commun 290 2002 1084 1089
6. S.S. Mirza, K. Shafique, A.R. Shaikh, N.A. Khan, and M. Anwar Qureshi Association between circulating adiponectin levels and polycystic ovarian syndrome J Ovarian Res 7 2014 18
7. H. Lee, J.Y. Oh, and Y.A. Sung Adipokines, insulin-like growth factor binding protein-3 levels, and insulin sensitivity in women with polycystic ovary syndrome Korean J Intern Med 28 2013 456 463
8. B. Orlik, P. Madej, A. Owczarek, P. Skałba, J. Chudek, and M. Olszanecka-Glinianowicz Plasma omentin and adiponectin levels as markers of adipose tissue dysfunction in normal weight and obese women with polycystic ovary syndrome Clin Endocrinol (Oxf) 2013 Dec 9 http://dx.doi.org/10.1111/cen. 12381. [Epub ahead of print]
9. K. Hara, M. Horikoshi, T. Yamauchi, H. Yago, O. Miyazaki, and H. Ebinuma et al. Measurement of the high-molecular weight form of adiponectin in plasma is useful for the prediction of insulin resistance and metabolic syndrome Diabetes Care 29 2006 1357 1362
10. C. Lara-Castro, N. Luo, P. Wallace, R.L. Klein, and W.T. Garvey Adiponectin multimeric complexes and the metabolic syndrome trait cluster Diabetes 55 2006 249 259
11. R. Nakashima, N. Kamei, K. Yamane, S. Nakanishi, A. Nakashima, and N. Kohno Decreased total and high molecular weight adiponectin are independent risk factors for the development of type 2 diabetes in Japanese-Americans J Clin Endocrinol Metab 91 2006 3873 3877
12. D. Ferriman, and J.D. Gallwey Clinical assessment of body hair growth in women J Clin Endocrinol Metab 21 1961 1440 1447
13. E. Ludwig Classification of the types of androgenetic alopecia (common baldness) occurring in the female sex Br J Dermatol 97 1977 247 254
14. N. Hayashi, H. Akamatsu, and M. Kawashima Establishment of grading criteria for acne severity J Dermatol 35 2008 255 260
15. E. Guastella, R.A. Longo, and E. Carmina Clinical and endocrine characteristics of the main polycystic ovary syndrome phenotypes Fertil Steril 94 2010 2197 2201
16. Diagnosis and classification of diabetes mellitus American Diabetes Association. Diabetes Care 28 Suppl 1 2005 S37 S42
17. D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher, and R.C. Turner Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 1985 412 419
18. J. Yin, M. Li, L. Xu, Y. Wang, H. Cheng, and X. Zhao et al. Insulin resistance determined by Homeostasis Model Assessment (HOMA) and associations with metabolic syndrome among Chinese children and teenagers Diabetol Metab Syndr 5 2013 71
19. M.D. Kahsar-Miller, C. Nixon, L.R. Boots, R.C. Go, and R. Azziz Prevalence of polycystic ovary syndrome (PCOS) in first-degree relatives of patients with PCOS Fertil Steril 75 2001 53 58
20. R.S. Legro, D. Driscoll, J.F. Strauss 3rd, J. Fox, and A. Dunaif Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome Proc Natl Acad Sci U S A 95 1998 14956 14960
21. A.D. Coviello, S. Sam, R.S. Legro, and A. Dunaif High prevalence of metabolic syndrome in first-degree male relatives of women with polycystic ovary syndrome is related to high rates of obesity J Clin Endocrinol Metab 94 2009 4361 4366
22. A. Moini, and B. Eslami Familial associations between polycystic ovarian syndrome and common diseases J Assist Reprod Genet 26 2009 123 127
23. S. Sam, R.S. Legro, R. Bentley-Lewis, and A. Dunaif Dyslipidemia and metabolic syndrome in the sisters of women with polycystic ovary syndrome J Clin Endocrinol Metab 90 2005 4797 4802
24. S. Sam, Y.A. Sung, R.S. Legro, and A. Dunaif Evidence for pancreatic beta-cell dysfunction in brothers of women with polycystic ovary syndrome Metabolism 57 2008 84 89
25. A. Trottier, M.C. Battista, D.H. Geller, B. Moreau, A.C. Carpentier, and J. Simoneau-Roy et al. Adipose tissue insulin resistance in peripubertal girls with first-degree family history of polycystic ovary syndrome Fertil Steril 98 2012 1627 1634
26. N. Raissouni, A. Kolesnikov, R. Purushothaman, S. Sinha, S. Bhandari, and A. Bhangoo et al. Altered glucose disposition and insulin sensitivity in peri-pubertal first-degree relatives of women with polycystic ovary syndrome Int J Pediatr Endocrinol 2012 2012 14
27. A. Dokras, M. Bochner, E. Hollinrake, S. Markham, B. Vanvoorhis, and D.H. Jagasia Screening women with polycystic ovary syndrome for metabolic syndrome Obstet Gynecol 106 2005 131 137
28. L.J. Moran, M.L. Misso, R.A. Wild, and R.J. Norman Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis Hum Reprod Update 16 2010 347 363
29. F. Orio, S. Palomba, and A. Colao Cardiovascular risk in women with polycystic ovary syndrome Fertil Steril 86 Suppl 1 2006 S20 S21
30. A.D. Coviello, R.S. Legro, and A. Dunaif Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance J Clin Endocrinol Metab 91 2006 492 497
31. N.I. Leibel, E.E. Baumann, M. Kocherginsky, and R.L. Rosenfield Relationship of adolescent polycystic ovary syndrome to parental metabolic syndrome J Clin Endocrinol Metab 91 2006 1275 1283
32. J. Huang, R. Ni, X. Chen, L. Huang, Y. Mo, and D. Yang Metabolic abnormalities in adolescents with polycystic ovary syndrome in south China Reprod Biol Endocrinol 8 2010 142
33. A.H. Roe, E. Prochaska, M. Smith, M. Sammel, and A. Dokras Using the androgen excess-PCOS society criteria to diagnose polycystic ovary syndrome and the risk of metabolic syndrome in adolescents J Pediatr 162 2013 937 941
34. B. Rossi, S. Sukalich, J. Droz, A. Griffin, S. Cook, and A. Blumkin et al. Prevalence of metabolic syndrome and related characteristics in obese adolescents with and without polycystic ovary syndrome J Clin Endocrinol Metab 93 2008 4780 4786
35. A. Fulghesu, R. Magnini, E. Portoghese, S. Angioni, L. Minerba, and G.B. Melis Obesity-related lipid profile and altered insulin incretion in adolescents with polycystic ovary syndrome J Adolesc Health 46 2010 474 481
36. P. Villa, A. Rossodivita, F. Sagnella, M.C. Moruzzi, N. Mariano, and A.P. Lassandro et al. Ovarian volume and gluco-insulinaemic markers in the diagnosis of PCOS during adolescence Clin Endocrinol (Oxf) 78 2013 285 290
37. P. Poomthavorn, W. Chaya, P. Mahachoklertwattana, M. Sukprasert, and S. Weerakiet Glucose metabolism in obese and lean adolescents with polycystic ovary syndrome J Pediatr Endocrinol Metab 26 2013 319 324
38. C.A. Flannery, B. Rackow, X. Cong, E. Duran, D.J. Selen, and T.S. Burgert Polycystic ovary syndrome in adolescence: impaired glucose tolerance occurs across the spectrum of BMI Pediatr Diabetes 14 2013 42 49
39. A. O'Connor, N. Phelan, T.K. Tun, G. Boran, J. Gibney, and H.M. Roche High-molecular-weight adiponectin is selectively reduced in women with polycystic ovary syndrome independent of body mass index and severity of insulin resistance J Clin Endocrinol Metab 95 2010 1378 1385
40. K.C. Lewandowski, K. Szosland, C. O'Callaghan, B.K. Tan, H.S. Randeva, and A. Lewinski Adiponectin and resistin serum levels in women with polycystic ovary syndrome during oral glucose tolerance test: a significant reciprocal correlation between adiponectin and resistin independent of insulin resistance indices Mol Genet Metab 85 2005 61 69
41. K.J. Mather, A.E. Hunt, H.O. Steinberg, G. Paradisi, G. Hook, and A. Katz et al. Repeatability characteristics of simple indices of insulin resistance: implications for research applications J Clin Endocrinol Metab 86 2001 5457 5464